최고 Biotechnology 팟캐스트 (2023)

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases

14d ago

—

Researchers from West Virginia University College of Law have conducted a study examining the frequency of drug patent invalidations based on inequitable conduct. The findings, published in JAMA, shed light…The post Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases appeared first on DrugPatentWatch - Make Better De…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
AI-Driven Strategies: Pharma’s Answer to Patent Expirations

19d ago

—

In a recent article in Pharmaceutical Executive, Alan Kalton, Senior Vice President of Commercial Strategy at Aktana, sheds light on the critical challenges facing pharmaceutical companies as they confront impending…The post AI-Driven Strategies: Pharma’s Answer to Patent Expirations appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents

25d ago

—

A paper titled “Analysis of Strategy for Extending Patent Protection of Rucaparib” by Zhifeng Wang. discusses the strategies employed by pharmaceutical companies to extend the patent protection period of the…The post Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents appeared first on DrugPatentWatch …

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma

1M ago

—

Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical…The post Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma appeared …

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
List of research papers citing DrugPatentWatch

1M ago

—

DrugPatentWatch has published a list of research papers citing DrugPatentWatch at https://www.drugpatentwatch.com/citations/ DrugPatentWatch.com is your key to unlocking the world of pharmaceutical research. These primary literature citations can benefit researchers,…The post List of research papers citing DrugPatentWatch appeared first on DrugPate…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Influencers of Generic Drug Utilization

2M ago

—

In a systematic review titled “Influencers of Generic Drug Utilization,” researchers aimed to shed light on the key factors influencing the use of generic prescription drugs in the United States.…The post Influencers of Generic Drug Utilization appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Reviving an R&D Pipeline

2M ago

—

The article titled “Reviving an R&D Pipeline: A Step Change in the Phase II Success Rate” discusses Pfizer’s efforts to improve its research and development (R&D) productivity. The pharmaceutical industry…The post Reviving an R&D Pipeline appeared first on DrugPatentWatch - Make Better Decisions.저자 DrugPatentWatch

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Factors that May Predict the Likelihood of Generic Drug Marketing Applications

2M ago

—

The FDA conducted a study to identify factors that may predict the likelihood of generic drug marketing applications. The study focused on abbreviated new drug applications (ANDAs) submitted to the…The post Factors that May Predict the Likelihood of Generic Drug Marketing Applications appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Measuring Patent Value Indicators

2M ago

—

“Measuring Patent Value Indicators with Patent Renewal Information” aims to address the research gap by constructing a dynamic model that incorporates both ex ante and ex post patent value indicators.…The post Measuring Patent Value Indicators appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Maximizing Drug Patents’ Value: Strategies for Biomedical Companies

2M ago

—

The article “Maximizing the Value of Drug Patents Before Losing Exclusivity” discusses strategies for biomedical companies to maximize the value of their drug patents before the exclusivity period expires. In…The post Maximizing Drug Patents’ Value: Strategies for Biomedical Companies appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO

3M ago

—

In a recent STAT article Sanofi CEO Paul Hudson discusses the potential of artificial intelligence (AI) in the pharmaceutical industry. While some in the industry have been hesitant to embrace…The post From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Understanding Patent Term Extensions: An Overview

3M ago

—

In the world of patents, the right to exclude others from using or selling an invention is granted only during the patent’s validity. Once a patent expires, this exclusivity vanishes.…The post Understanding Patent Term Extensions: An Overview appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Pharmacists Can Play Key Role in Drug Repurposing

3M ago

—

Pharmacists play a crucial role in drug repurposing due to the vast amount of opportunities that exist in this innovative approach. Drug development and registration can be costly, time-consuming, and…The post Pharmacists Can Play Key Role in Drug Repurposing appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Key Factors for Choosing the Right CDMO

3M ago

—

In a guest column Kevin Wall, principal consultant and owner of Cincero Consulting, emphasizes the critical importance of selecting the right Contract Development and Manufacturing Organization (CDMO) for drug product…The post Key Factors for Choosing the Right CDMO appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

3M ago

—

Loss of exclusivity (LOE) doesn’t have to spell doom for branded drug revenue streams. In the face of impending patent expirations, pharmaceutical companies can adopt key approaches to preserve meaningful…The post Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry appeared first on DrugPatentWatch - Make Be…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

4M ago

—

A recent paper in Expert Opinion on Biological Therapy studies failed fillings for biosimilar drugs. Over the past three decades, biotherapeutics have revolutionized healthcare by providing effective treatments for complex diseases…The post Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review appeared first on DrugPatentW…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Drug Patent Reports now available on Amazon

4M ago

—

DrugPatentWatch now offers single drug reports for purchase on Amazon. These reports provide valuable insights and information about specific drugs. This convenient availability on Amazon allows users to easily access…The post Drug Patent Reports now available on Amazon appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Artificial Intelligence and Machine Learning in Drug Discovery and Development

4M ago

—

A recent paper published in the journal “Intelligent Medicine” article discusses various aspects of using AI and machine learning in the pharmaceutical industry for drug discovery and development. Results The…The post Artificial Intelligence and Machine Learning in Drug Discovery and Development appeared first on DrugPatentWatch - Make Better Decis…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Prevalence and timing of authorized generics in the US market

4M ago

—

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding. The article sheds…The post Prevalence and timing of authorized generics in the US market appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends

4M ago

—

A recent update from Foley & Lardner attorney Courtenay C. Brinckerhoff discusses trends in Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings involving Orange Book and biologic patents, based…The post Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

4M ago

—

In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies. Reverse payment cases…The post The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation appeared first on DrugPatentWatch -…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study

4M ago

—

In the world of prescription drugs, brand-name manufacturers have employed various strategies to maintain revenue streams in the face of generic competition. One such strategy is the use of “authorized…The post Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study appeared first on DrugPatentWatch - Make Better …

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

4M ago

—

A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020. The study…The post Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations appeared first on DrugP…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugPatentWatch reveals NIH funding for patents

4M ago

—

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public Interest Protections of…The post DrugPatentWatch reveals NIH funding for patents appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Filing Strategies for Maximizing Pharma Patents

4M ago

—

In a recent article published by IAM Magazine, titled “Why Pharma Companies Should File Patents Later In The R&D Process,” Alexander R. Trimble, PhD, a prominent patent attorney, explores the…The post Filing Strategies for Maximizing Pharma Patents appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
17th Edition Project Portfolio and Resource Management Excellence for Pharma

6M ago

—

17th Edition Project Portfolio and Resource Management Excellence for Pharma July 11-13, 2023 | Sheraton Philadelphia University City Hotel | Philadelphia, PA Mastering Resource and Project Prioritization, Operational Excellence, and People Development…The post 17th Edition Project Portfolio and Resource Management Excellence for Pharma appeared fi…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugChatter Featured Questions

6M ago

—

DrugChatter recently launched as an experimental AI chat-based business intelligence tool. Here’s some of the more interesting questions it’s been asked: Cost savings for bulk lipitor Who Invented Advil? What…The post DrugChatter Featured Questions appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights

6M ago

—

Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform that redefines the way professionals obtain concise, cited information on…The post DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights appeared first on DrugPatentWatch - M…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
NPR and DrugPatentWatch – Can drug injector pens be swapped?

7M ago

—

On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which could then be swapped to fix drug shortages. Referring to…The post NPR and DrugPatentWatch – Can drug injector pens be swapped? appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges

8M ago

—

This article was originally published by Jiayi Chen, Zhifeng Zhao, Xinyu Wang and Jingjun Huang in Drug Repurposing – Advances, Scopes and Opportunities in Drug Discovery and is republished here…The post Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges appeared first o…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Social Return on Investment

1y ago

—

This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at sales@digitalho.com Commercial, nonprofit, and government companies are quite good at calculating the costs…The post Social Return on Investment appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
CDCDB: A large and continuously updated drug combination database

1+ y ago

—

This article was originally published by Guy Shtar, Louise Azulay, Omer Nizri, Lior Rokach & Bracha Shapira in Scientific Data volume 9, Article number: 263 under a Creative Commons Attribution…The post CDCDB: A large and continuously updated drug combination database appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugPatentWatch named “Best of the Web” by Genetic Engineering News

1+ y ago

—

DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile highlighted the “new training modules designed to help you find…The post DrugPatentWatch named “Best of the Web” by Genetic Engineering News appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
The value of method of use patent claims in protecting your therapeutic assets

1+ y ago

—

This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted at raymond.miller@dlapiper.com. When it comes to protecting therapeutic assets, I…The post The value of method of use patent claims in protecting your therapeutic assets appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugPatentWatch Week in Review

1+ y ago

—

FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications…The post DrugPatentWatch Week in Review appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents

1+ y ago

—

Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are included in oral products for various reasons, such as to…The post 2 Strategies to Grow Your Excipient Business by Tracking Drug Patents appeared first on DrugPatentWatch - Make Bett…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Free Online Course on Drug Patents, Generic and Branded Drugs

1+ y ago

—

DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry. The positive responses received made it apparent that the course…The post Free Online Course on Drug Patents, Generic and Branded Drugs appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform

2y ago

—

DrugPatentWatch has been ranked the “Best Biopharmaceuticals Commercial Business Intelligence Platform” by Global Health & Pharma News This award is dedicated to honoring the innovation, determination and outstanding levels of…The post DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform appeared first on DrugPat…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugPatentWatch Custom Market Surveillance

2y ago

—

DrugPatentWatch’s Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle. You’re monitoring your business, but you’re too busy to sift through data.…The post DrugPatentWatch Custom Market Surveillance appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Updating the DrugPatentWatch Biologics Module

2y ago

—

Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the law should not be passed. Thankfully, the Act advanced, and…The post Updating the DrugPatentWatch Biologics Module appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

2y ago

—

This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg Wichard, Mario Lobell, and Alexander Hillisch in Drug Discovery Today…The post Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades appeared first on DrugPatentWatc…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review

2y ago

—

This paper was originally published by Md. Imtiaz Hasan et al in Journal of Biosciences and Medicines under a Creative Commons Attribution 4.0 International License Abstract Development of generic drug product…The post Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review appeared first on DrugPa…

B

Biotechnology

1
Biotechnology 2:14

2y ago2:14

2:14

Its definition Uses Tissue culture processes

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Generic Portfolio Management, Partnering with Brands, and Staying Competitive

2y ago

—

This is my talk from the 14th Annual Portfolio Planning and Partnership for Generic Conference. I discuss: Identifying generic entry opportunities at the earliest stages Discovering opportunities that avoid litigation…The post Generic Portfolio Management, Partnering with Brands, and Staying Competitive appeared first on DrugPatentWatch - Make Bett…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Workshop and lecture on generic portfolio management

2y ago

—

I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…The post Workshop and lecture on generic portfolio management appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Upcoming workshop on generic portfolio management

2+ y ago

—

I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…The post Upcoming workshop on generic portfolio management appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management

2+ y ago

—

Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management. We’ll be sharing our expertise and best practices for strategic…The post DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management appeared first on DrugPatentWatch - Make Better Decisions.…

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Strategies for Pricing Generic Drugs

2+ y ago

—

When it comes to pricing generic drugs, there are a number of factors that come into play. In countries without drug price regulations, the pricing is based largely on profitability.…The post Strategies for Pricing Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.저자 DrugPatentWatch

D

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

1
Free Course in Generic and Branded Drug Lifecycle Management

2+ y ago

—

Want insights into the biggest revenue-changing events? ➤ Get Your Certificate Today By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay…The post Free Course in Generic and Branded Drug Lifecycle Management appeared first on DrugPatentWatch - Make Better Deci…

B

Biotechnology for Tomorrow

1
Biotechnology for Tomorrow: GMO Edition 7:09

2+ y ago7:09

7:09

Season 1: Episode 1

들어볼 가치가 있는 팟캐스트

Biotechnology 팟 캐스트

들어볼 가치가 있는 팟캐스트

빠른 참조 가이드